Merck Seeks 2017 World Rabies Day Awards submissionsJune 6, 2017For the second consecutive year, Merck Animal Health (MSD Animal Health outside the U.S. and Canada) will recognize individuals and organizations who work to prevent rabies in their communities through the World Rabies Day Awards.
SPONSORED CONTENTSwitch to Triple Protection in One Monthly DoseSee the difference of triple protection with the one monthly chew. + Learn More
Study: Universal canine vaccination eliminates human exposure to rabiesMarch 15, 2017MSD Animal Health/Merck Animal Health has announced the publication of a new study in the journal Vaccine, which demonstrates that universal canine vaccination is an effective public health policy for eliminating human rabies exposure.
Merck announces call for submission for new poultry awardMarch 14, 2017Interested in studying poultry? Then you may get a chance to talk to experts in the poultry field thanks to Merck Animal Health’s new High Quality Poultry Science Award.
Merck dog flu vaccine approvedJanuary 18, 2017The U.S. Department of Agriculture has approved Nobivac Canine Flu Bivalent, which manufacturer Merck Animal Health described as the first vaccine formulated to control subtypes H3N8 and H3N2.
Merck, AVMF partner together to offer vet student scholarshipsNovember 15, 2016Merck Animal Health, along with the American Veterinary Medical Foundation (AVMF), is offering twenty $5,000 scholarships to second- and third-year veterinary students through the Veterinary Student Scholarship Program. Veterinary students in the U.S., Canada and the Caribbean have until December 31, 2016, to apply.
Diabetes Pet Care Alliance Program calls on vets to participate in programOctober 5, 2016November is National Diabetes Month, and the Diabetes Pet Care Alliance is once again encouraging veterinarians to enroll in their program.
Bravecto topical approved for cats, dogsJuly 26, 2016Merck Animal Health is preparing a feline version of Bravecto, a two-year-old flea and tick preventive for dogs. The Madison, N.J., company reported that the new spot-on medication, Bravecto Topical, earned U.S. Food and Drug Administration approval and should go on sale later this year.
